Literature DB >> 14514921

A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples.

S-F Chin1, Y Daigo, H-E Huang, N G Iyer, G Callagy, T Kranjac, M Gonzalez, T Sangan, H Earl, C Caldas.   

Abstract

AIMS: To describe a robust pretreatment protocol for preparing paraffin wax embedded tissues on tissue microarrays for fluorescence in situ hybridisation (FISH). The newly developed pretreatment protocol described here was compared with the commonly used sodium thiocyanate based protocol and two different heating methods used in standard antigen unmasking protocols for immunohistochemistry (pressure cooking and microwaving in citrate acid buffer).
METHODS: Dewaxed tissue sections were incubated in 10mM citric acid buffer at 80 degrees C for 30 minutes to two hours, followed by a short pepsin digestion (1-5 mg/ml). Pretreated tissues were co-denatured with DNA probes at 80 degrees C for 10 minutes, followed by hybridisation at 37 degrees C for 48-72 hours.
RESULTS: The three protocols using citrate acid buffer produced FISH signals with superior signal to noise ratios compared with sodium thiocyanate pretreatment. Most importantly, the best tissue attachment was achieved using the newly developed pretreatment protocol: on tissue microarrays less than 1% of cores were lost. To date, a total of 30 probes have been successfully hybridised on to breast tissue and multi-tissue microarrays.
CONCLUSION: This pretreatment protocol is easy, reproducible, and facilitates FISH on tissue microarrays, with potential for widespread application in cancer research.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514921      PMCID: PMC1187338          DOI: 10.1136/mp.56.5.275

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  18 in total

1.  Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.

Authors:  S R Shi; M E Key; K L Kalra
Journal:  J Histochem Cytochem       Date:  1991-06       Impact factor: 2.479

Review 2.  In situ hybridization and its diagnostic applications in pathology.

Authors:  A M McNicol; M A Farquharson
Journal:  J Pathol       Date:  1997-07       Impact factor: 7.996

Review 3.  Antigen retrieval, signal amplification and intensification in immunohistochemistry.

Authors:  M Werner; R Von Wasielewski; P Komminoth
Journal:  Histochem Cell Biol       Date:  1996-04       Impact factor: 4.304

4.  Formation and detection of RNA-DNA hybrid molecules in cytological preparations.

Authors:  J G Gall; M L Pardue
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

5.  Molecular hybridization of radioactive DNA to the DNA of cytological preparations.

Authors:  M L Pardue; J G Gall
Journal:  Proc Natl Acad Sci U S A       Date:  1969-10       Impact factor: 11.205

Review 6.  Fluorescence in situ hybridization in cancer and radiation biology.

Authors:  J W Gray; D Pinkel; J M Brown
Journal:  Radiat Res       Date:  1994-03       Impact factor: 2.841

7.  Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.

Authors:  A H Hopman; E van Hooren; C A van de Kaa; P G Vooijs; F C Ramaekers
Journal:  Mod Pathol       Date:  1991-07       Impact factor: 7.842

8.  On the chemistry of formaldehyde fixation and its effects on immunohistochemical reactions.

Authors:  H Puchtler; S N Meloan
Journal:  Histochemistry       Date:  1985

9.  Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.

Authors:  M Dowsett; J Bartlett; I O Ellis; J Salter; M Hills; E Mallon; A D Watters; T Cooke; C Paish; P M Wencyk; S E Pinder
Journal:  J Pathol       Date:  2003-04       Impact factor: 7.996

Review 10.  The clinical evaluation of HER-2 status: which test to use?

Authors:  John Bartlett; Elizabeth Mallon; Tim Cooke
Journal:  J Pathol       Date:  2003-04       Impact factor: 7.996

View more
  21 in total

1.  TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma.

Authors:  David W Scott; Karen L Mungall; Susana Ben-Neriah; Sanja Rogic; Ryan D Morin; Graham W Slack; King L Tan; Fong Chun Chan; Raymond S Lim; Joseph M Connors; Marco A Marra; Andrew J Mungall; Christian Steidl; Randy D Gascoyne
Journal:  Blood       Date:  2012-04-11       Impact factor: 22.113

2.  Standardised fluorescence in situ hybridisation in cytological and histological specimens.

Authors:  Ludwig Wilkens; Heidrun Gerr; Dorothea Gadzicki; Hans Kreipe; Brigitte Schlegelberger
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

Review 3.  Fluorescent in situ hybridization on tissue microarrays: challenges and solutions.

Authors:  Lindsay A Brown; David Huntsman
Journal:  J Mol Histol       Date:  2007-01-10       Impact factor: 2.611

4.  Fluorescence In Situ Hybridization of Cells, Chromosomes, and Formalin-Fixed Paraffin-Embedded Tissues.

Authors:  Ahmad Alamri; Jun Yeb Nam; Jan K Blancato
Journal:  Methods Mol Biol       Date:  2017

5.  Molecular features of a large cohort of primary central nervous system lymphoma using tissue microarray.

Authors:  Diego Villa; King L Tan; Christian Steidl; Susana Ben-Neriah; Muntadhar Al Moosawi; Tamara N Shenkier; Joseph M Connors; Laurie H Sehn; Kerry J Savage; David W Scott; Randy D Gascoyne; Graham W Slack
Journal:  Blood Adv       Date:  2019-12-10

6.  Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis.

Authors:  David De Semir; Mehdi Nosrati; Vladimir Bezrookove; Altaf A Dar; Scot Federman; Geraldine Bienvenu; Suraj Venna; Javier Rangel; Joan Climent; Tanja M Meyer Tamgüney; Suresh Thummala; Schuyler Tong; Stanley P L Leong; Chris Haqq; Paul Billings; James R Miller; Richard W Sagebiel; Robert Debs; Mohammed Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-17       Impact factor: 11.205

7.  Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer.

Authors:  Bjørn Naume; Xi Zhao; Marit Synnestvedt; Elin Borgen; Hege Giercksky Russnes; Ole Christian Lingjaerde; Maria Strømberg; Gro Wiedswang; Gunnar Kvalheim; Rolf Kåresen; Jahn M Nesland; Anne-Lise Børresen-Dale; Therese Sørlie
Journal:  Mol Oncol       Date:  2007-04-04       Impact factor: 6.603

8.  Analysis of FOXO1 mutations in diffuse large B-cell lymphoma.

Authors:  Diane L Trinh; David W Scott; Ryan D Morin; Maria Mendez-Lago; Jianghong An; Steven J M Jones; Andrew J Mungall; Yongjun Zhao; Jacqueline Schein; Christian Steidl; Joseph M Connors; Randy D Gascoyne; Marco A Marra
Journal:  Blood       Date:  2013-03-04       Impact factor: 22.113

9.  Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer.

Authors:  Frank McCaughan; Jessica C M Pole; Alan T Bankier; Bernard A Konfortov; Bernadette Carroll; Mary Falzon; Terence H Rabbitts; P Jeremy George; Paul H Dear; Pamela H Rabbitts
Journal:  Am J Respir Crit Care Med       Date:  2010-03-18       Impact factor: 21.405

10.  DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure.

Authors:  E Kettunen; M Aavikko; P Nymark; S Ruosaari; H Wikman; E Vanhala; K Salmenkivi; R Pirinen; A Karjalainen; E Kuosma; S Anttila
Journal:  Br J Cancer       Date:  2009-03-31       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.